Author

Kenneth Wyman

Observed names: K. Wyman, Kenneth W. Wyman

Institutions: Veterans Health Administration, VA Tennessee Valley Healthcare System, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Observed institutions: Vanderbilt University, Veterans Health Administration, Sarah Cannon, VA Tennessee Valley Healthcare System, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

OpenAlex ID: A5113557903

Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease

2020 · Wade T. Iams, Prasad R. Kopparapu, et al. · JTO Clinical and Research Reports · 22

Impact of the influenza vaccination on cancer patients undergoing therapy with immune checkpoint inhibitors (ICI).

2018 · Ragisha Gopalakrishnan, Douglas Buckner Johnson, et al. · Journal of Clinical Oncology · 15

A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma

2015 · Tejaswi V. Mudigonda, Kenneth Wyman, et al. · Pigment Cell & Melanoma Research · 14

A multicenter phase II study of erlotinib and bevacizumab in patients with metastatic melanoma

2007 · K. Wyman, D. Spigel, et al. · Journal of Clinical Oncology · 14

Association of Adherence to Quality Metrics with Recurrence or Mortality among Veterans with Colorectal Cancer

2020 · Gretchen C. Edwards, Richard L. Martin, et al. · Journal of Gastrointestinal Surgery · 9

Phase II study of erlotinib given daily for patients with metastatic melanoma (MM)

2006 · K. Wyman, M. Kelley, et al. · Journal of Clinical Oncology · 7

Abstract B20: Prolonged time to clearance of circulating-tumor DNA from patients with limited-stage small-cell lung cancer is associated with inferior progression-free and overall survival

2020 · Christopher Cann, Prasad Kopparapu, et al. · Clinical Cancer Research

A Phase I Study of Neoadjuvant Cyclooxygenase-2 Inhibition and Chemoradiation for Stage II/III Rectal Cancer

2007 · R. Reddy, N. Merchant, et al. · International Journal of Radiation Oncology*Biology*Physics

Antimetabolites

2007 · Kenneth W. Wyman, Igor Puzanov, et al. · Birkhäuser Basel eBooks

Preliminary results of a phase II study of cyclooxygenase-2 (COX-2) inhibition in rectal cancer

2004 · B. Chakravarthy, C. Schmidt, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 10

Citation count: 81

H-index: 6

I10-index: 4